Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK

Inflammation is a key homeostatic process involved in the body’s response to a multitude of disease states including infection, autoimmune disorders, cancer, and other chronic conditions. When the initiating event is poorly controlled, severe inflammation and globally dysregulated immune responses c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jackline Joy Martín Lasola, Andrea L. Cottingham, Brianna L. Scotland, Nhu Truong, Charles C. Hong, Paul Shapiro, Ryan M. Pearson
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
TLR
Acceso en línea:https://doaj.org/article/1592704ca67e4380840c5bbd9144f8b6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1592704ca67e4380840c5bbd9144f8b6
record_format dspace
spelling oai:doaj.org-article:1592704ca67e4380840c5bbd9144f8b62021-11-25T18:41:05ZImmunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK10.3390/pharmaceutics131118411999-4923https://doaj.org/article/1592704ca67e4380840c5bbd9144f8b62021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1841https://doaj.org/toc/1999-4923Inflammation is a key homeostatic process involved in the body’s response to a multitude of disease states including infection, autoimmune disorders, cancer, and other chronic conditions. When the initiating event is poorly controlled, severe inflammation and globally dysregulated immune responses can occur. To address the lack of therapies that efficaciously address the multiple aspects of the dysregulated immune response, we developed cargo-less immunomodulatory nanoparticles (iNPs) comprised of poly(lactic acid) (PLA) with either poly(vinyl alcohol) (PVA) or poly(ethylene-alt-maleic acid) (PEMA) as stabilizing surfactants and investigated the mechanisms by which they exert their inherent anti-inflammatory effects. We identified that iNPs leverage a multimodal mechanism of action by physically interfering with the interactions between pathogen-associated molecular patterns (PAMPs) and bone marrow-derived macrophages (BMMΦs). Additionally, we showed that iNPs mitigate proinflammatory cytokine secretions induced by LPS via a time- and composition-dependent abrogation of NF-κB p65 and p38 MAPK activation. Lastly, inhibition studies were performed to establish the role of a pH-sensing G-protein-coupled receptor, GPR68, on contributing to the activity of iNPs. These data provide evidence for the multimodal mechanism of action of iNPs and establish their potential use as a novel therapeutic for the treatment of severe inflammation.Jackline Joy Martín LasolaAndrea L. CottinghamBrianna L. ScotlandNhu TruongCharles C. HongPaul ShapiroRyan M. PearsonMDPI AGarticleinflammationinnate immunitymacrophagesToll-like receptorsTLRNF-κBPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1841, p 1841 (2021)
institution DOAJ
collection DOAJ
language EN
topic inflammation
innate immunity
macrophages
Toll-like receptors
TLR
NF-κB
Pharmacy and materia medica
RS1-441
spellingShingle inflammation
innate immunity
macrophages
Toll-like receptors
TLR
NF-κB
Pharmacy and materia medica
RS1-441
Jackline Joy Martín Lasola
Andrea L. Cottingham
Brianna L. Scotland
Nhu Truong
Charles C. Hong
Paul Shapiro
Ryan M. Pearson
Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK
description Inflammation is a key homeostatic process involved in the body’s response to a multitude of disease states including infection, autoimmune disorders, cancer, and other chronic conditions. When the initiating event is poorly controlled, severe inflammation and globally dysregulated immune responses can occur. To address the lack of therapies that efficaciously address the multiple aspects of the dysregulated immune response, we developed cargo-less immunomodulatory nanoparticles (iNPs) comprised of poly(lactic acid) (PLA) with either poly(vinyl alcohol) (PVA) or poly(ethylene-alt-maleic acid) (PEMA) as stabilizing surfactants and investigated the mechanisms by which they exert their inherent anti-inflammatory effects. We identified that iNPs leverage a multimodal mechanism of action by physically interfering with the interactions between pathogen-associated molecular patterns (PAMPs) and bone marrow-derived macrophages (BMMΦs). Additionally, we showed that iNPs mitigate proinflammatory cytokine secretions induced by LPS via a time- and composition-dependent abrogation of NF-κB p65 and p38 MAPK activation. Lastly, inhibition studies were performed to establish the role of a pH-sensing G-protein-coupled receptor, GPR68, on contributing to the activity of iNPs. These data provide evidence for the multimodal mechanism of action of iNPs and establish their potential use as a novel therapeutic for the treatment of severe inflammation.
format article
author Jackline Joy Martín Lasola
Andrea L. Cottingham
Brianna L. Scotland
Nhu Truong
Charles C. Hong
Paul Shapiro
Ryan M. Pearson
author_facet Jackline Joy Martín Lasola
Andrea L. Cottingham
Brianna L. Scotland
Nhu Truong
Charles C. Hong
Paul Shapiro
Ryan M. Pearson
author_sort Jackline Joy Martín Lasola
title Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK
title_short Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK
title_full Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK
title_fullStr Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK
title_full_unstemmed Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK
title_sort immunomodulatory nanoparticles mitigate macrophage inflammation via inhibition of pamp interactions and lactate-mediated functional reprogramming of nf-κb and p38 mapk
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/1592704ca67e4380840c5bbd9144f8b6
work_keys_str_mv AT jacklinejoymartinlasola immunomodulatorynanoparticlesmitigatemacrophageinflammationviainhibitionofpampinteractionsandlactatemediatedfunctionalreprogrammingofnfkbandp38mapk
AT andrealcottingham immunomodulatorynanoparticlesmitigatemacrophageinflammationviainhibitionofpampinteractionsandlactatemediatedfunctionalreprogrammingofnfkbandp38mapk
AT briannalscotland immunomodulatorynanoparticlesmitigatemacrophageinflammationviainhibitionofpampinteractionsandlactatemediatedfunctionalreprogrammingofnfkbandp38mapk
AT nhutruong immunomodulatorynanoparticlesmitigatemacrophageinflammationviainhibitionofpampinteractionsandlactatemediatedfunctionalreprogrammingofnfkbandp38mapk
AT charleschong immunomodulatorynanoparticlesmitigatemacrophageinflammationviainhibitionofpampinteractionsandlactatemediatedfunctionalreprogrammingofnfkbandp38mapk
AT paulshapiro immunomodulatorynanoparticlesmitigatemacrophageinflammationviainhibitionofpampinteractionsandlactatemediatedfunctionalreprogrammingofnfkbandp38mapk
AT ryanmpearson immunomodulatorynanoparticlesmitigatemacrophageinflammationviainhibitionofpampinteractionsandlactatemediatedfunctionalreprogrammingofnfkbandp38mapk
_version_ 1718410817148289024